A few months before Terry Shaw became CEO of Adventist Health System, he got a call that his wife, Paula, was unconscious in the ED, after a truck collided with her pickup. Paula recovered from the accident—but the "nightmare" the Shaws experienced navigating post-acute care inspired Terry to launch a care navigation program at his own system, Ellie Kincaid writes for Forbes.
The tech companies expect the deal to close in 2019, in today's bite-sized hospital and health industry news from California, Minnesota, New Hampshire, New Jersey, and Pennsylvania.
FDA Commissioner Scott Gottlieb says the agency's "approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of [its] longstanding commitment to advance access to lower cost, safe, and effective generic alternatives once patents and other exclusivities no longer prevent approval."
The law directs the Federal Communications Commission to work with HHS and Veterans Affairs to determine the feasibility of establishing a three-digit dialing code to connect callers with a mental health crisis and suicide prevention hotline, similar to how U.S. residents can dial 9-1-1 to be connected with emergency services.
Thomas Biegi, a Pfizer spokesperson, said the company cannot track Depo-Medrol's off-label use for epidural shots and without the FDA banning such use, the company cannot prevent providers from prescribing the shots off-label.
Rafael Rivera, the associate dean for admission and financial aid for NYU School of Medicine, said, "This is going to be a huge game-changer for us, for our students and for our patients," adding that "[t]here's really a moral imperative to reduce the amount of debt people have."
